IPIRA Startups

IPIRA Startups

Exelixis, Inc.

Brief Description

Exelixis, Inc. is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for difficult-to-treat cancers. Following early work in model genetic systems, the company established a broad drug discovery and development platform that has served as the foundation for its continued efforts to bring new cancer therapies to patients in need. The company developed CABOMETYX® (cabozantinib), COMETRIQ® (cabozantinib) and COTELLIC® (cobimetinib), and partnered with leading...

Aurora Algae Inc.

Brief Description

Aurora Algae produced premium, algae-based products for the pharmaceutical, nutrition, aquaculture and fuels markets.

Formerly known as Aurora Biofuels.

Timeline 2006. Company founded 2015. Acquired by Reliance Industries Inventors

Anastasios Melis, Mautusi Mitra

Acrigen Biosciences, Inc.

Brief Description

Acrigin Biosciences is developing Precision Gene Editing Systems to harness the power of CRISPR for use in human therapeutics. Acrigen’s proprietary technology leverages novel αCas and μCas CRISPR gene editors coupled with ErAcrs (engineered anti-CRISPR proteins) to create an editing toolbox with best-in-class efficiency and precision. The company's technology will expand the impact of CRISPR by improving the efficacy and safety of novel gene editing therapies.

Timeline 2019. Company founded Inventors

Jennifer Doudna, Christof Fellmann, Haridha...

Adura Technologies

Brief Description

Adura Technologies provides wireless lighting and energy management systems to improve energy efficiency and facilitate cost savings.

Adura Technologies was acquired by Acuity Brands in 2013.

Timeline 2005. Company founded 2013. Adura Technologies acquired by Acuity Brands Inventor

Charlie Huizenga

3C Energy Corporation

Brief Description

The company builds modular systems to capture and convert ambient carbon dioxide to value-added products such as fuels, biopolymers, pharmaceuticals, industrial enzymes, commodity chemicals, and biomass.

Timeline 2021. Company founded Inventor

Douglas Clark

Molecular Dynamics

Brief Description

The development of high speed, high throughput and highly accurate DNA sequencing methods was one prerequisite for the success of the Human Genome Project. In answer to this need, Richard Mathies and his lab at UC Berkeley developed a new method called capillary array electrophoresis (CAE) where multiple separations could be performed in parallel using bundles of microcapillaries and allowed the generation of over 2.8 million bases in 24 h.

Molecular Dynamics was acquired by Nycomed Amersham Pharmacia Biotech for approximately $256 million in 1998. Amersham was...

Opus Biosciences

Brief Description

The mission of Opus Biosciences is to advance the field of lipid nanoparticle delivery through the development of safer, higher efficacy, cost effective, and exceedingly efficient LNPs, surpassing industry standards. Opus is committed to unlocking existing limitations within the drug delivery space by enabling more frequent re-dosing, reducing toxicity, and improving and expanding therapeutic targets. The foundational technology was invented in the lab of Bioengineering Professor Niren Murthy at the UC Berkeley Innovative Genomics Institute.

Timeline 2023....

Avametric

Brief Description

Avametric technology enables brands to deliver accurate 3D renderings of their apparel & accessories on customizable digital body models for web, mobile, and augmented reality. With the proprietary software, business can recreate a real-world fitting room experience online, making it possible for customers to try on garments virtually with a personalized 3D avatar. The company was born out of ARCSims adaptive refining and corsening simulator technology developed in the lab of UC Berkeley Professor of Computer Sciences James O'Brien. Dr. O'Brien co-founded Avametric,...

PhenomeX

Brief Description

PhenomeX empowered Digital Cell Biology by combining bioscience, technology and information in unique new ways to accelerate science. The platforms, assays and services, biologists can move faster and more efficiently to meet the demands for cell based processes in biotherapeutic discovery and development, cellular therapy manufacturing, synthetic biology, ag-bio, and other fields.

Formerly known as Berkeley Lights, Inc.

Timeline 2011. Year founded 2020. Initial public offering on the Nasdaq stock exchange under the ticker...

Amyris, Inc.

Brief Description

Amyris, Inc. is an industrial biotechnology company, which engages in the provision of bioscience solutions. It focuses on the research, development, manufacture, and sale of fuels and farnesene-derived products. Its products include cosmetics, flavors and fragrances, performance materials, diesel, jet fuel, and lubricants. The company was founded by Jack D. Newman, Kinkead Keith Reiling, and Neil Renninger on July 17, 2003 and is headquartered in Emeryville, CA.

Inventors Jay Keasling, Artem Khlebnikov, Seon Won Kim, James Kirby, Vincent Martin, Jack Newman, Eric...